Pharmabiz19h
NUS scientists develop realistic ‘micro-gut’ model to study the relationship between gut microbes and human diseases
NUS scientists develop realistic ‘micro-gut’ model to study the relationship between gut microbes and human diseases: Our ...
Pharmabiz12h
Novartis to buy Boston-based clinical-stage biopharma company, Anthos Therapeutics for up to $3.1 billion
Novartis to buy Boston-based clinical-stage biopharma company, Anthos Therapeutics for up to $3.1 billion: Basel Tuesday, February 11, 2025, 17:45 Hrs [IST] Novartis announced tha ...
Pharmabiz13h
Nutrify competes five years of innovation in nutrition now marks its US entry with new office in Somerset, New Jersey
Nutrify competes five years of innovation in nutrition now marks its US entry with new office in Somerset, New Jersey: Our Bureau, Bengaluru Tuesday, February 11, 2025, 16:50 Hrs ...
Pharmabiz13h
Even Healthcare’s works on lowering post-surgery care readmissions by 50%, plans to open new hospitals
Even Healthcare’s works on lowering post-surgery care readmissions by 50%, plans to open new hospitals: Our Bureau, Bengaluru Tuesday, February 11, 2025, 16:15 Hrs [IST] Even He ...
Pharmabiz12h
CARsgen’s first enrolled subject in the THANK-u Plus platform-based allogeneic CAR-T trial achieves sCR at week 4
CARsgen’s first enrolled subject in the THANK-u Plus platform-based allogeneic CAR-T trial achieves sCR at week 4: Shanghai, China Tuesday, February 11, 2025, 18:00 Hrs [IST] CA ...
Pharmabiz16h
PHC and CCRM collaborate to develop primary T-cell expansion culture processes to enhance efficiency and improve cell quality
PHC and CCRM collaborate to develop primary T-cell expansion culture processes to enhance efficiency and improve cell quality: Tokyo, Japan Tuesday, February 11, 2025, 14:00 Hrs [ ...
Pharmabiz17h
Syngene International announces appointment of Peter Bains as CEO designate
Syngene International announces appointment of Peter Bains as CEO designate: Our Bureau, Bengaluru Tuesday, February 11, 2025 ...
Pharmabiz20h
Bayer seeks European approval of extended 6-month treatment interval for Eylea 8 mg to treat nAMD & diabetic macular edema
Bayer seeks European approval of extended 6-month treatment interval for Eylea 8 mg to treat nAMD & diabetic macular edema: Berlin Tuesday, February 11, 2025, 10:00 Hrs [IST] Baye ...
Pharmabiz18h
Marengo Asia Hospital in Gurgaon opens its second clinic in South City Park 2
Marengo Asia Hospital in Gurgaon opens its second clinic in South City Park 2: Our Bureau, Chennai Tuesday, February 11, 2025, 12:10 Hrs [IST] Continuing their mission to expand i ...
Pharmabiz14h
Asia Pharma Expo to showcase cutting-edge advancements in mfg
Asia Pharma Expo to showcase cutting-edge advancements in mfg: Our Bureau, Mumbai Tuesday, February 11, 2025, 15:40 Hrs [IST] The 16th Asia Pharma Expo 2025 & Asia Lab Expo 2025, ...
Pharmabiz18h
AliveDx seeks US FDA 510(k) premarket approval for MosaiQ AiPlex CD multiplex microarray
AliveDx seeks US FDA 510(k) premarket approval for MosaiQ AiPlex CD multiplex microarray: Eysins, Switzerland Tuesday, February 11, 2025, 12:00 Hrs [IST] AliveDx, an established c ...
Pharmabiz17h
Dentalkart enters Rs. 6,000 crore dental lab market with ‘Smileworks’
Dentalkart, India's leading online marketplace for dental supplies, has taken a significant step forward in its commitment to advancing dental care with the launch of its new subsidiary, Smileworks.